首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >Formulation and In-Vitro Evaluation of Ocular Ciprofloxacin-Containing Minitablets Prepared with Different Combinations of Carbopol 974P and Various Cellulose Derivatives
【2h】

Formulation and In-Vitro Evaluation of Ocular Ciprofloxacin-Containing Minitablets Prepared with Different Combinations of Carbopol 974P and Various Cellulose Derivatives

机译:Carbopol 974P和各种纤维素衍生物不同组合制备的含眼环丙沙星的小片剂的配制及体外评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was preparation and evaluation of ciprofloxacin-containing minitablets for ocular use, in an attempt to obtain prolonged and controlled drug release to the anterior eye segment.Following initial studies on ciprofloxacin powder, it was formulated into ocular minitablets. For this purpose, ciprofloxacin along with various amounts of different sustained release cellulose derivatives (HPMC, Na CMC, HEC and EC), Carbopol 974P, solubilizer and lubricant were directly compressed into minitablets, using concave 3 mm diameter punches. All the prepared formulations were evaluated in terms of physicochemical tests, including uniformity of weight, friability, crushing strength, water uptake and in-vitro drug release studies.It was found that the type and amount of cellulose derivatives used, can influence the rate of drug release.The finally selected formulation (B3) contained ethyl cellulose, Carbopol 974P, mannitol, sodium stearyl fumarate and ciprofloxacin, which showed more than 80% drug release over a period of 5h, and complied well in all the physicochemical tests conducted.Based on kinetic studies, formulation B3 was found to best fit the zero order equation. However, the Higuchi and Hixson-Crowell models also showed a good fit. Hence, overall formulation B3 was chosen as the best formulation.
机译:这项研究的目的是制备和评估含环丙沙星的眼用微片,以期延长和控制药物向眼前段的释放。在对环丙沙星粉进行初步研究之后,将其制成眼用微片。为此,使用直径3 mm的凹形冲头将环丙沙星与各种不同量的不同持续释放纤维素衍生物(HPMC,Na CMC,HEC和EC),Carbopol 974P,增溶剂和润滑剂直接压制成微型片剂。对所有制备的制剂进行了理化测试,包括重量均匀性,易碎性,抗碎强度,吸水率和体外药物释放研究,发现所使用的纤维素衍生物的类型和数量会影响药物的使用率。最终选择的制剂(B3)含有乙基纤维素,Carbopol 974P,甘露醇,硬脂富马酸钠和环丙沙星,在5小时内显示出80%以上的药物释放,并且完全符合所进行的所有理化测试。在动力学研究中,发现配方B3最适合零级方程。但是,Higuchi和Hixson-Crowell模型也显示出很好的拟合度。因此,选择整体配方B3作为最佳配方。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号